64 related articles for article (PubMed ID: 26214359)
1. Carbohydrate-based materials for targeted delivery of drugs and genes to the liver.
Ahmed M; Narain R
Nanomedicine (Lond); 2015 Jul; 10(14):2263-88. PubMed ID: 26214359
[TBL] [Abstract][Full Text] [Related]
2. Multivalent Targeting of the Asialoglycoprotein Receptor by Virus-Like Particles.
Hincapie R; Bhattacharya S; Baksh MM; Sanhueza CA; Echeverri ES; Kim H; Paunovska K; Podilapu AR; Xu M; Dahlman JE; Finn MG
Small; 2023 Dec; 19(52):e2304263. PubMed ID: 37649182
[TBL] [Abstract][Full Text] [Related]
3. Human Lectins, Their Carbohydrate Affinities and Where to Find Them.
Raposo CD; Canelas AB; Barros MT
Biomolecules; 2021 Jan; 11(2):. PubMed ID: 33572889
[TBL] [Abstract][Full Text] [Related]
4. Galactosylated albumin nanoparticles of simvastatin.
Ganesh K; Archana D; Preeti K
Iran J Pharm Res; 2015; 14(2):407-15. PubMed ID: 25901147
[TBL] [Abstract][Full Text] [Related]
5. Glycosylated Nanoparticles for Cancer-Targeted Drug Delivery.
Torres-Pérez SA; Torres-Pérez CE; Pedraza-Escalona M; Pérez-Tapia SM; Ramón-Gallegos E
Front Oncol; 2020; 10():605037. PubMed ID: 33330106
[TBL] [Abstract][Full Text] [Related]
6. Unlocking the power of sugar: carbohydrate ligands as key players in nanotherapeutic-assisted targeted cancer therapy.
Swami R; Vij S; Sharma S
Nanomedicine (Lond); 2024 Feb; 19(5):431-453. PubMed ID: 38288611
[TBL] [Abstract][Full Text] [Related]
7. Anti-Cancer Drug Delivery Using Carbohydrate-Based Polymers.
Ranjbari J; Mokhtarzadeh A; Alibakhshi A; Tabarzad M; Hejazi M; Ramezani M
Curr Pharm Des; 2018 Feb; 23(39):6019-6032. PubMed ID: 28482782
[TBL] [Abstract][Full Text] [Related]
8. Critical Review in Designing Plant-Based Anticancer Nanoparticles against Hepatocellular Carcinoma.
Basu A; Namporn T; Ruenraroengsak P
Pharmaceutics; 2023 May; 15(6):. PubMed ID: 37376061
[TBL] [Abstract][Full Text] [Related]
9. CD44 In Sarcomas: A Comprehensive Review and Future Perspectives.
Fernández-Tabanera E; Melero-Fernández de Mera RM; Alonso J
Front Oncol; 2022; 12():909450. PubMed ID: 35785191
[TBL] [Abstract][Full Text] [Related]
10. Drug Targeting and Nanomedicine: Lessons Learned from Liver Targeting and Opportunities for Drug Innovation.
Salvati A; Poelstra K
Pharmaceutics; 2022 Jan; 14(1):. PubMed ID: 35057111
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular-Targeted mRNA Delivery Using Functionalized Selenium Nanoparticles In Vitro.
Singh D; Singh M
Pharmaceutics; 2021 Feb; 13(3):. PubMed ID: 33668320
[TBL] [Abstract][Full Text] [Related]
12. Nanotechnology as a Platform for the Development of Injectable Parenteral Formulations: A Comprehensive Review of the Know-Hows and State of the Art.
Shetab Boushehri MA; Dietrich D; Lamprecht A
Pharmaceutics; 2020 Jun; 12(6):. PubMed ID: 32503171
[TBL] [Abstract][Full Text] [Related]
13. Targeted Gene Silencing BRAF Synergized Photothermal Effect Inhibits Hepatoma Cell Growth Using New GAL-GNR-siBRAF Nanosystem.
Liu Y; Tan M; Zhang Y; Huang W; Min L; Peng S; Yuan K; Qiu L; Min W
Nanoscale Res Lett; 2020 May; 15(1):116. PubMed ID: 32449085
[TBL] [Abstract][Full Text] [Related]
14. Nanoparticles Based on Novel Carbohydrate-Functionalized Polymers.
Raposo CD; Conceição CA; Barros MT
Molecules; 2020 Apr; 25(7):. PubMed ID: 32290160
[TBL] [Abstract][Full Text] [Related]
15. A Non-Viral Plasmid DNA Delivery System Consisting on a Lysine-Derived Cationic Lipid Mixed with a Fusogenic Lipid.
Martínez-Negro M; Sánchez-Arribas N; Guerrero-Martínez A; Moyá ML; Tros de Ilarduya C; Mendicuti F; Aicart E; Junquera E
Pharmaceutics; 2019 Nov; 11(12):. PubMed ID: 31783620
[TBL] [Abstract][Full Text] [Related]
16. Quantification of Surface GalNAc Ligands Decorating Nanostructured Lipid Carriers by UPLC-ELSD.
Gauthier L; Varache M; Couffin AC; Lebrun C; Delangle P; Gateau C; Texier I
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31726778
[TBL] [Abstract][Full Text] [Related]
17. Review of polysaccharide particle-based functional drug delivery.
Barclay TG; Day CM; Petrovsky N; Garg S
Carbohydr Polym; 2019 Oct; 221():94-112. PubMed ID: 31227171
[TBL] [Abstract][Full Text] [Related]
18. Development of asialoglycoprotein receptor directed nanoparticles for selective delivery of curcumin derivative to hepatocellular carcinoma.
Yousef S; Alsaab HO; Sau S; Iyer AK
Heliyon; 2018 Dec; 4(12):e01071. PubMed ID: 30603704
[TBL] [Abstract][Full Text] [Related]
19. Enrichment-triggered prodrug activation demonstrated through mitochondria-targeted delivery of doxorubicin and carbon monoxide.
Zheng Y; Ji X; Yu B; Ji K; Gallo D; Csizmadia E; Zhu M; Choudhury MR; De La Cruz LKC; Chittavong V; Pan Z; Yuan Z; Otterbein LE; Wang B
Nat Chem; 2018 Jul; 10(7):787-794. PubMed ID: 29760413
[TBL] [Abstract][Full Text] [Related]
20. Recombinant Proteins and Monoclonal Antibodies.
Jefferis R
Adv Biochem Eng Biotechnol; 2021; 175():281-318. PubMed ID: 29071407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
